Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2004, p. 924-929, Vol. 48, No. 3
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.3.924-929.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Laboratoires d'Immunologie et de Parasitologie, E.A. 3677, Bases Thérapeutiques Anti-Infectieuses et Anti-Inflammatoires, Université Bordeaux II,1 Service de Médecine Interne et des Maladies Tropicales, Hôpital Saint André, Bordeaux,2 Unilever France, Rueil-Malmaison, France3
Received 11 July 2003/ Returned for modification 13 October 2003/ Accepted 29 November 2003
In addition to parasite spread, the severity of disease observed in cases of human African trypanosomiasis (HAT), or sleeping sickness, is associated with increased levels of inflammatory mediators, including tumor necrosis factor (TNF)-
and nitric oxide derivatives. In the present study, quercetin (3,3',4',5,7-pentahydroxyflavone), a potent immunomodulating flavonoid, was shown to directly induce the death of Trypanosoma brucei gambiense, the causative agent of HAT, without affecting normal human cell viability. Quercetin directly promoted T. b. gambiense death by apoptosis as shown by Annexin V binding. In addition to microbicidal activity, quercetin induced dose-dependent decreases in the levels of TNF-
and nitric oxide produced by activated human macrophages. These results highlight the potential use of quercetin as an antimicrobial and anti-inflammatory agent for the treatment of African trypanomiasis.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»